Session Learning Objectives

Those attending this session will receive information that should allow them to:

• Discuss the history of early identification of clinical high risk (CHR) and the signs and symptoms;
• Identify diagnostic tools standardized to assess for CHR;
• Describe differential diagnosis conventions; and
• Summarize evidence-informed treatments for CHR